A case for rescheduling psilocybin and MDMA based on 13,000 submissions favoring change. Standard antidepressants achieve remission in 15-30% of patients; PTSD treatments work in 5-10%. Psilocybin and MDMA-assisted therapy show 60-80% remission rates in two to three sessions.
Chapters
I mean, there was over 13,000 submissions from researchers, clinicians, patients, and their carers, and 98% of those submissions were in favor of the rescheduling. So at the end of the day, when you have that many people demanding change, it's very, very difficult for anybody to then say no, given the levels of suffering. And you know, many of these people are veterans and first responders, people who've served the nation and have gone through terrible traumas, and they deserve the chance to heal. And current treatments, as you'd be well aware, in the case of antidepressants, in only about 15 to maximum 30% of patients going to remission. And in the case of post-traumatic stress disorder, as few as 5 to 10% of patients are going to remission from existing treatments. Now you compare that against the 60 to 80% remission rates after just 2 to 3 treatments of psilocybin or MDMA with a short course of psychotherapy.